Related Experiment Video
Updated: Jun 23, 2026

The Efficacy and Underlying Pathway Mechanisms of ShiDuGao Treatment for Anus Eczema Based on GEO Datasets and Network Pharmacology
Published on: January 12, 2024
The effects of selected probiotic strains on the development of eczema (the PandA study)
1Department of Pediatrics, Wilhelmina Children's' Hospital, University Medical Center, Utrecht, the Netherlands.
Insights
Probiotic supplementation with Bifidobacterium bifidum, Bifidobacterium lactis, and Lactococcus lactis reduced eczema incidence in high-risk infants. The preventive effect on eczema was observed within the first 3 months and sustained for 2 years.
Area of Science:
- Microbiology and Immunology
- Pediatric Allergy and Dermatology
Background:
- Intestinal microbiota modulation via probiotics is a potential strategy for preventing allergic diseases.
- High-risk infants (positive family history of allergy) were studied for primary prevention of allergic disease.
Purpose of the Study:
- To investigate the efficacy of pre- and postnatal probiotic supplementation in preventing allergic disease in high-risk children.
- To assess the impact of a specific probiotic mixture on eczema incidence and related immune markers.
Main Methods:
- A double-blind, randomized, placebo-controlled trial was conducted.
- Mothers of high-risk children received a probiotic mixture (Bifidobacterium bifidum, Bifidobacterium lactis, Lactococcus lactis) prenatally and their offspring for the first 12 months.
- Parental reports and in vitro immune responses were monitored.
Main Results:
- Eczema incidence was significantly lower in the probiotic group during the first 3 months (6/50 vs 15/52, P=0.035).
- Eczema incidence became similar after 3 months, but cumulative incidence remained lower in the intervention group at 1 and 2 years.
- The probiotic group showed increased Lactococcus lactis colonization and decreased IL-5 production at 3 months.
Conclusions:
- This probiotic combination demonstrates a preventive effect on eczema in high-risk children.
- The preventive effect is established early, within the first 3 months, and sustained for up to 2 years.
- Probiotic-induced changes in Lc. lactis colonization and IL-5 production may contribute to eczema prevention.
Background:
Modification of the intestinal microbiota by administration of probiotic bacteria may be a potential approach to prevent allergic disease. We aimed to study primary prevention of allergic disease in high-risk children by pre- and postnatal supplementation of selected probiotic bacteria.
Methods:
In a double-blind, randomized, placebo-controlled trial, a mixture of probiotic bacteria selected by in-vitro experiments (Bifidobacterium bifidum, Bifidobacterium lactis, and Lactococcus lactis; Ecologic Panda) was prenatally administered to mothers of high-risk children (i.e. positive family history of allergic disease) and to their offspring for the first 12 months of life.
Results:
Parental-reported eczema during the first 3 months of life was significantly lower in the intervention group compared with placebo, 6/50 vs 15/52 (P = 0.035). After 3 months, the incidence of eczema was similar in both groups. Cumulative incidence of parental-reported eczema at 1 and 2 years was 23/50 (intervention) vs 31/48 (placebo) and 27 (intervention) vs 34 (placebo), respectively. The number needed to treat was 5.9 at age 3 and 12 months and 6.7 at age 2 years. The intervention group was significantly more frequently colonized with higher numbers of Lc. lactis. Furthermore, at age 3 months, in vitro production of IL-5 (146 pg/ml vs 72 pg/ml; P = 0.04) was decreased in the probiotic-group compared with the placebo-group.
Conclusions:
This particular combination of probiotic bacteria shows a preventive effect on the incidence of eczema in high-risk children, which seems to be sustained during the first 2 years of life. In addition to previous studies, the preventive effect appears to be established within the first 3 months of life.
Related Concept Videos
Development of Human Microbiota
Probiotics
Microbiota Modulation by Antibiotics

